Lisa A. Beck
Co-Director
Credentials: · · · ·
History
Present- Present
- Present
- 1992–1994
1987–1990
Research
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
New England Journal of Medicine · 2016 · 1,611 citations
Review · Nature Reviews Disease Primers · 2018 · 1,315 citations
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis
New England Journal of Medicine · 2014 · First of 19 authors · 1,125 citations
- DL
34 papers
- LS
34 papers
32 papers · 2 as a resident
- JH
27 papers
26 papers
- MB
26 papers
25 papers
25 papers
Grants
- 2020–2027
Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $3.2M · University of Rochester
- 2022
Overall Atopic Dermatitis Research Network
National Institute of Allergy and Infectious Diseases · U19
Project lead · $1.5M · National Jewish Health
- 2012–2017
Effect of the PPAR Agonist Pioglitazone on Epidermal Barrier in Atopic Dermatitis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $379.7K · University of Rochester
- 2001–2007
Mechanisms of Chemokine-Induced Inflammation in Humans
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.6M · Johns Hopkins University
Clinical trials
- 2018–2019
Scratch and Sleep Quantification in Atopic Dermatitis
Principal investigator · Completed
University of Rochester
- 2014–2017
Bleach Bath Treatment of Adults With Atopic Dermatitis
Principal investigator · Completed
University of Rochester
- 2013–2014
Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients
Principal investigator · Withdrawn
University of Rochester
- 2008–2009
In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis
Principal investigator · Completed
Lucid, Inc.